Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03135158
Other study ID # 3009
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 18, 2017
Est. completion date December 5, 2017

Study information

Verified date April 2018
Source Gynuity Health Projects
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The present study aims to determine the relationship between postpartum changes in the shock index and the severity of blood loss and other PPH results. Blood loss, heart rate and blood pressure will be systematically measured in the postpartum period in all participating women to explore new clinical indicators to identify those requiring clinical intervention for excessive bleeding.


Recruitment information / eligibility

Status Completed
Enrollment 298
Est. completion date December 5, 2017
Est. primary completion date November 30, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Receive care for vaginal delivery

Exclusion Criteria:

- Scheduled or transferred for cesarean section

- Cannot give informed consent

- Are not willing and/or cannot answer the questionnaire on their background

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exposure to vaginal delivery
Women who have vaginal births are observed for a minimum of 1 hour postpartum

Locations

Country Name City State
Colombia Fundación Valle del Lili Cali

Sponsors (2)

Lead Sponsor Collaborator
Gynuity Health Projects Fundacion Clinica Valle del Lili

Country where clinical trial is conducted

Colombia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between blood loss and shock index Correlate shock index, heart rate, and blood pressure measurements with blood loss levels at 15, 30, 45 & 60 minutes Within 1 hour postpartum
Secondary Percentage of women with blood loss = 500 ml and = 1000 ml Proportions with = 500 ml and = 1000 ml blood loss at 30 and 60 minutes postpartum, at PPH diagnosis (if applicable), and when active bleeding stops Up to two hours postpartum
Secondary Median blood loss in the postpartum and interquartile range Blood loss at 30 and 60 minutes postpartum, at PPH diagnosis (if applicable), and when active bleeding stops Up to two hours postpartum
Secondary Percentage of women who received treatment to control bleeding Up to two hours postpartum
Secondary Average change in Hb measured before and after delivery Among women receiving treatment to control postpartum hemorrhage Pre-delivery and at least 24 hours postpartum
Secondary Percentage of women with complications Among women receiving treatment to control postpartum hemorrhage Through study completion, an average of 24-48 hours postpartum
See also
  Status Clinical Trial Phase
Completed NCT03434444 - In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol N/A
Terminated NCT01980173 - Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care N/A
Not yet recruiting NCT06033170 - Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage N/A
Not yet recruiting NCT02319707 - Management of the Third Stage of Labor Phase 3
Completed NCT02163616 - Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study Phase 3
Recruiting NCT01600612 - Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial N/A
Completed NCT02079558 - Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section Phase 2
Withdrawn NCT01108302 - Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India N/A
Completed NCT00097123 - RCT of Misoprostol for Postpartum Hemorrhage in India N/A
Completed NCT02883673 - Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage N/A
Completed NCT02542813 - Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers Phase 1
Completed NCT04201665 - EMG for Uterotonic Efficiency Estimation N/A
Terminated NCT03246919 - Ideal Time of Oxytocin Infusion During Cesarean Section Phase 4
Not yet recruiting NCT05501106 - Reducing Postpartum Hemorrhage After Vaginal Delivery N/A
Completed NCT05429580 - Prophylactic Tranexamic Acid Use After Vaginal Delivery N/A
Terminated NCT03064152 - Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery N/A
Recruiting NCT05382403 - Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage N/A
Not yet recruiting NCT02853552 - Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding Phase 4
Completed NCT03344302 - Oxytocin Administration During Cesarean Section Phase 4
Completed NCT02805426 - Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage Phase 4